Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.
Resistance Training and Amino Pyridine in Multiple Sclerosis
A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
† Indicates status has not been verified in more than two years